William Blair & Company
CDLX icon

William Blair & Company’s Cardlytics CDLX Stock Holding History

William Blair & Company’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,752
Closed -$963K – 1874
2022
Q1 		$963K Sell
1,752
-960
-35% -$580K ﹤0.01% 936
2021
Q4 		$1.79M Sell
2,712
-927
-25% -$709K 0.01% 757
2021
Q3 		$3.06M Sell
3,639
-1,567
-30% -$1.59M 0.01% 580
2021
Q2 		$6.61M Sell
5,206
-124
-2% -$140K 0.02% 401
2021
Q1 		$5.85M Sell
5,330
-2,191
-29% -$2.89M 0.02% 421
2020
Q4 		$10.7M Buy
7,521
+535
+8% +$571K 0.04% 288
2020
Q3 		$4.93M Sell
6,986
-18
-0.3% -$13.1K 0.02% 406
2020
Q2 		$4.9M Buy
7,004
+3,487
+99% +$2.01M 0.02% 385
2020
Q1 		$1.23M Buy
3,517
+375
+12% +$266K 0.01% 620
2019
Q4 		$1.98M Buy
3,142
+762
+32% +$373K 0.01% 609
2019
Q3 		$798K Buy
+2,380
New +$763K ﹤0.01% 817

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

William Blair & Company's CDLX Position: Q2 2022 in Review

William Blair & Company sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 1,752 shares — an estimated $963K sold.

William Blair & Company first reported a position in CDLX in Q3 2019 and held it in 11 quarters. The position peaked at $10.7M in Q4 2020. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • William Blair & Company reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • William Blair & Company sold 1,752 Cardlytics shares in Q2 2022, an estimated $963K.
  • William Blair & Company first reported a position in Cardlytics in Q3 2019 and held it in 11 quarters.
  • William Blair & Company's Cardlytics position peaked at $10.7M in Q4 2020.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on William Blair & Company's 13F filing for Q2 2022, filed 10 Aug 2022.